Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 12, 2004

View Archived Issues

Single and dual GSK-3/PKC inhibitors prepared and tested at Janssen

New HCV NS3 protease inhibitors under study at BMS

Millennium claims the preparation and use of chemokine CCR9 antagonists

Two novel series of HDAC inhibitors discovered at Beacon

Novartis identifies aliskiren-related renin inhibitors as antihypertensive agents

New SGLT2 inhibitor for use in type 2 diabetes covered by BMS patent

Pliva researchers design two series of TNF-alpha/IL-1 production inhibitors

Tigecycline is effective against Staphylococcus epidermis biofilms

ViaCell announces collaboration with Amgen

Pfizer and Akzo Nobel's Organon collaboration moves forward

Merger of Novuspharma into Cell Therapeutics completed

Tentative approval for Sicor's fluconazole aNDA

Symlin marketing application withdrawn in Switzerland

Aventis and Crucell enter PER.C6 agreement for novel influenza vaccines

University of Rochester to study rhIGF-I/rhIGFBP-3 for myotonic dystrophy

Keryx to acquire Access Oncology

New small molecule collaboration between Infinity and Amgen

Biopure and the FDA discuss complete response letter for Hemopure BLA

ImmunoGen to advance TAP compounds into proof-of-concept trials

Pain Therapeutics announces H1 2004 milestones

Paladin to market Watson's Oxytrol in Canada

Hemispherx Biopharma accelerates SARS program

NCX-4016 reaches primary efficacy endpoint in phase IIa PAOD study

UroGene to develop besipirdine for overactive bladder

Perlegen and Pfizer collaborate on metabolic syndrome research

Palonosetron reported safe and more effective than ondansetron against CINV

Lipid-lowering effects of lovastatin and a diet containing cholesterol-lowering foods

Attenuated inflammatory response to sepsis found with N-acetylcysteine

Anticoagulant protein rNAPc2 increases survival of rhesus macaques infected with Ebola virus

Improved antibiotic activity of novel desmycosin analogues described

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...